AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Debt to Equity Ratio: -0.0806 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2023 | -0.0806 |
June 30, 2023 | -1.489 |
March 31, 2023 | -1.511 |
December 31, 2022 | -1.053 |
September 30, 2022 | -1.036 |
June 30, 2022 | -1.038 |
March 31, 2022 | -0.9409 |
December 31, 2021 | -1.116 |
September 30, 2021 | -1.148 |
June 30, 2021 | -1.106 |
Date | Value |
---|---|
March 31, 2021 | -1.213 |
December 31, 2020 | -1.231 |
September 30, 2020 | -1.483 |
June 30, 2020 | -1.631 |
March 31, 2020 | -2.391 |
December 31, 2019 | 0.6889 |
September 30, 2019 | 0.044 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-2.391
Minimum
Mar 2020
0.6889
Maximum
Dec 2019
-0.9852
Average
-1.111
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 12.21M |
Total Liabilities (Quarterly) | 39.86M |
Shareholders Equity (Quarterly) | -27.54M |
Current Ratio | 0.3561 |
Net Debt Paydown Yield | 0.25% |